{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:45:13Z","timestamp":1753875913128,"version":"3.41.2"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Classic Hodgkin lymphoma is a potentially curable disease. With the advent of effective systemic regimens with adriamycin, bleomycin, vincristine, and dacarbazine, chemotherapy has become the treatment of choice for advanced Hodgkin lymphoma. However, for advanced Hodgkin lymphoma after chemotherapy, disease relapse rates are still high. This case report highlights how low-dose palliative radiotherapy can be used successfully for the management of an unusual case of recurrent lymphoma with a different histology soon after completing systemic therapy, which was further complicated by an ongoing local infection.<\/jats:p>","DOI":"10.1093\/bjrcr\/uaad010","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:13:27Z","timestamp":1704845607000},"source":"Crossref","is-referenced-by-count":0,"title":["Low-dose palliative radiotherapy for malignant peripheral T-cell lymphoma masked by cellulitis and osteomyelitis: a case report"],"prefix":"10.1093","volume":"10","author":[{"given":"Yasir","family":"Alayed","sequence":"first","affiliation":[{"name":"Radiation Oncology Unit, Department of Medicine, College of Medicine, King Saud University , Riyadh 12372, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"issue":"2","key":"2024011113295996600_uaad010-B1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3322\/caac.21438","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2024011113295996600_uaad010-B2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ncponc1186","article-title":"Treatment of Hodgkin lymphoma: the past, present, and future","volume":"5","author":"Evens","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"issue":"4","key":"2024011113295996600_uaad010-B3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.2003.12.086","article-title":"Randomized comparison of ABVD and MOPP\/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial","volume":"21","author":"Duggan","year":"2003","journal-title":"J Clin Oncol"},{"issue":"12","key":"2024011113295996600_uaad010-B4","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1200\/JCO.1991.9.12.2193","article-title":"Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations","volume":"9","author":"Yahalom","year":"1991","journal-title":"J Clin Oncol"},{"issue":"20","key":"2024011113295996600_uaad010-B5","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1200\/JCO.2009.26.0323","article-title":"Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519)","volume":"28","author":"Johnson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"2024011113295996600_uaad010-B6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/jcp.2003.011882","article-title":"Cutaneous T cell lymphoma and classic Hodgkin lymphoma of the B cell type within a single lymph node: composite lymphoma","volume":"57","author":"Steinhoff","year":"2004","journal-title":"J Clin Pathol"},{"issue":"3","key":"2024011113295996600_uaad010-B7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","article-title":"4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Hoskin","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"2024011113295996600_uaad010-B8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hon.2368","article-title":"Low-dose radiotherapy in diffuse large B-cell lymphoma","volume":"35","author":"Furlan","year":"2016","journal-title":"Hematol Oncol"}],"container-title":["BJR|Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjrcr\/advance-article-pdf\/doi\/10.1093\/bjrcr\/uaad010\/54584829\/uaad010.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjrcr\/article-pdf\/10\/1\/uaad010\/55435034\/uaad010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjrcr\/article-pdf\/10\/1\/uaad010\/55435034\/uaad010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T14:36:36Z","timestamp":1705070196000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjrcr\/article\/7477652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,13]]}},"URL":"https:\/\/doi.org\/10.1093\/bjrcr\/uaad010","relation":{},"ISSN":["2055-7159"],"issn-type":[{"type":"electronic","value":"2055-7159"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,12,13]]},"article-number":"uaad010"}}